Mechanisms for increased cardiovascular disease in chronic kidney dysfunction

Area of Science:

• Nephrology
• Cardiology
• Atherosclerosis Research

Background:

• Patients with chronic kidney disease (CKD) exhibit the highest risk for atherosclerotic cardiovascular disease (CVD).
• Existing interventions are insufficient to mitigate the elevated CVD incidence and mortality in CKD patients compared to other high-risk populations.
• This review examines traditional and CKD-specific risk factors, alongside macrophage foam cell formation mechanisms contributing to excess CVD in CKD.

Purpose of the Study:

• To review traditional and CKD-related risks for atherosclerotic cardiovascular disease (CVD).
• To investigate the mechanisms of macrophage foam cell formation in CKD.
• To understand the heightened CVD risk in patients with chronic kidney disease (CKD).

Main Methods:

• Literature review focusing on traditional and CKD-specific risk factors for CVD.
• Analysis of mechanisms underlying macrophage foam cell formation.
• Examination of lipid metabolism and inflammatory pathways in CKD.

Main Results:

• Hyperlipidemia (high LDL cholesterol) is a primary driver of atherogenesis in the general population but not the sole overriding risk for greater CVD in CKD.
• While not solely due to elevated serum lipids, CKD is linked to proatherogenic abnormal lipid metabolism.
• CKD-specific risks, including inflammation, mineral metabolism disturbances, and macrophage perturbations, are implicated in increased CVD risk.

Conclusions:

• Heightened CVD risk in CKD likely results from combined traditional and CKD-specific factors.
• Inflammation and altered lipid metabolism, particularly macrophage cholesterol homeostasis, are key mechanisms.
• Further research into these mechanisms is essential for developing effective CVD interventions in CKD patients.